Moskovitz B, Halachmi S, Sopov V, Burbara J, Horev N, Groshar D, Nativ O
Department of Urology, Bnai Zion Medical Center, Technion, Institute of Technology, Haifa, Israel.
J Endourol. 2006 Feb;20(2):102-6. doi: 10.1089/end.2006.20.102.
To measure the effect of PCNL on global and regional renal function using quantitative single-photon emission CT (SPECT) measurement of Tc-dimercaptosuccinic acid (DMSA) uptake by the kidneys (QDMSA).
A series of 47 male and 41 female patients with a mean age of 47 +/- 16 years were studied by sequential QDMSA examinations before and 1.5 to 24 months after PCNL. Among the 67 patients (76%) in whom PCNL was performed using upper- or lower-pole access, the function of the affected and nonaffected poles of the treated kidney was calculated separately.
There was no statistically significant difference in the uptake by the treated kidneys before versus after PCNL (11.9% +/- 5% v 11.6% +/- 5%; t = 0.9; P = 0.368). The total functional volume of the treated kidney was slightly decreased, from 235 cc +/- 62 cc to 224 cc +/- 59 cc (t = 2.7; P = 0.011). The percent of the injected isotope dose per cubic centimeter of tissue of the treated kidney was not affected (0.051 +/- 0.02 v 0.053 +/- 0.02; t = 0.86; P = 0.296). Regional assessment revealed a statistically significant decrease in the functional volume at the PCNL port of entry (91 cc +/- 30 cc v 82 cc +/- 27 cc; t = 2.64; P = 0.013). Regarding the percent of the injected dose per cubic centimeter of renal tissue, no statistically significant difference was found between the area of the kidney that underwent PCNL and the untreated area of the same kidney (0.049 +/- 0.02 v 0.05 +/- 0.02; t = 0.693; P = 0.494). The function of the contralateral kidneys remained unchanged (13.4% +/- 5.2% v 13.6% +/- 4.8%; t = 0.68; P = 0.5).
Despite the statistically significant decrease in the functional volume of the surgically treated region, neither total percent uptake nor percent of injected dose were reduced significantly. Further studies with long-term follow-up of treated kidneys are required.
采用定量单光子发射计算机断层扫描(SPECT)测量肾脏对锝-二巯基丁二酸(DMSA)的摄取(QDMSA),以评估经皮肾镜取石术(PCNL)对整体和局部肾功能的影响。
对47例男性和41例女性患者进行了系列研究,平均年龄47±16岁。在PCNL术前及术后1.5至24个月进行连续的QDMSA检查。在67例(76%)采用上极或下极入路进行PCNL的患者中,分别计算治疗肾的患侧和未患侧肾盏的功能。
PCNL术前与术后治疗肾的摄取量无统计学显著差异(11.9%±5%对11.6%±5%;t=0.9;P=0.368)。治疗肾的总功能体积略有下降,从235 cc±62 cc降至224 cc±59 cc(t=2.7;P=0.011)。每立方厘米治疗肾组织的注入同位素剂量百分比未受影响(0.051±0.02对0.053±0.02;t=0.86;P=0.296)。局部评估显示,PCNL入路端口处的功能体积有统计学显著下降(91 cc±30 cc对82 cc±27 cc;t=2.64;P=0.013)。关于每立方厘米肾组织的注入剂量百分比,PCNL操作区域与同一肾脏的未处理区域之间未发现统计学显著差异(0.049±0.02对0.05±0.02;t=0.693;P=0.494)。对侧肾脏的功能保持不变(13.4%±5.2%对13.6%±4.8%;t=0.68;P=0.5)。
尽管手术治疗区域的功能体积有统计学显著下降,但总摄取百分比和注入剂量百分比均未显著降低。需要对治疗后的肾脏进行长期随访的进一步研究。